Nikos Kouris a, *, Ignatios Ikonomidis b, Dimitra Kontogianni a, Peter Smith b, Petros Nihoyannopoulos b

Size: px
Start display at page:

Download "Nikos Kouris a, *, Ignatios Ikonomidis b, Dimitra Kontogianni a, Peter Smith b, Petros Nihoyannopoulos b"

Transcription

1 Eur J Echocardiography (2005) 6, 435e442 Mitral valve repair versus replacement for isolated non-ischemic mitral regurgitation in patients with preoperative left ventricular dysfunction. A long-term follow-up echocardiography study Nikos Kouris a, *, Ignatios Ikonomidis b, Dimitra Kontogianni a, Peter Smith b, Petros Nihoyannopoulos b a Western Attica General Hospital, Athens, Greece b Hammersmith Hospital, Imperial College, London, UK Received 12 October 2004; received in revised form 15 January 2005; accepted 21 January 2005 Available online 2 April 2005 KEYWORDS Mitral regurgitation; Depressed LV function; Mitral valve repair Abstract The aim of this study was to evaluate LV function, by means of echocardiography, after mitral valve repair () or mitral valve replacement () in patients (pts) with chronic degenerative mitral regurgitation (MR) and depressed LV systolic function during a 6-years follow-up (FU) period. Patients and methods: Forty-five pts with moderately severe or severe MR and preoperative EF % 50% were divided into 2 groups: group (27 pts, 19 mene8 women, aged 62 G 10 years) and group (18 pts, 8 mene10 women, aged 60 G 12 years). The cause of MR was myxomatous mitral valve disease (/: 16/8), endocarditis (0/4) and degenerative mitral valves with ruptured chordae tendineae (11/6). All pts underwent transthoracic echocardiography preoperatively, postoperatively and annually during the FU period (6 G 3 years). Results: In group, 5 pts died, 5 were lost to FU and 2 pts underwent due to failure. In group, 6 pts died, 3 were lost to FU and 1 was re-operated due to prosthetic valve endocarditis. Atrial fibrillation was similar between the 2 groups. pts demonstrated significant LVEDD decrease postoperatively which was persistent during FU (p! 0.05). LVESD also decreased (p! 0.05), VTI improved (p! 0.05), while FS and EF showed a trend to improve. In pts, LVEDD was decreased * Corresponding author. 4, Agiou Georgiou Street, 15236, N. Penteli, Athens, Greece. Tel.: C ; fax: C address: nikoskou@otenet.gr (N. Kouris) /$30 ª 2005 The European Society of Cardiology. Published by Elsevier Ltd. All rights reserved. doi: /j.euje

2 436 N. Kouris et al. (p! 0.05) but increased during FU (p! 0.05) and LVESD remained high, resulting in a decrease of FS and EF (p! 0.05). VTI remained unchanged (p Z NS). Conclusion: in pts with non-ischemic MR and preoperative LV dysfunction achieves better preservation of LV systolic indices than, probably due to preservation of the subvalvular apparatus and LV geometry. ª 2005 The European Society of Cardiology. Published by Elsevier Ltd. All rights reserved. Mitral valve repair (), when feasible, has become the procedure of choice for surgical treatment of chronic mitral regurgitation (MR) because it provides better postoperative clinical outcome than mitral valve replacement (). 1e5 Poor preoperative left ventricular (LV) function has been associated with an adverse clinical outcome 6 in patients with MR, while preoperative LV ejection fraction (EF) may be a powerful predictor of postoperative heart failure and death, 5 regardless of the type of surgery used for correction of chronic MR. This is generally attributed to the postoperative increase in LV afterload and abolition of the pop-off valve effect of the regurgitant leak, further decreasing the EF and cardiac output. 6 The better clinical outcome after is directly related to the preservation of the subvalvular apparatus resulting in preservation of LV geometry. Patients with a significant degree of LV systolic dysfunction (EF! 50%) should undergo surgical correction of MR because: (a) surgical correction, compared to medical treatment, improves prognosis and (b) reduces the incidence of congestive heart failure. 7,8 The purpose of this study was to evaluate the recovery of the preoperative LV function after mitral valve repair or replacement in patients with impaired systolic LV function due to chronic degenerative MR. We also tested the hypothesis that these patients may present a greater improvement of LV function after than after. Patients and methods Study population The study group consisted of 45 patients with isolated moderately severe or severe MR and impaired LV function, without other significant associated valvular or coronary artery disease, documented by preoperative echocardiographic and cardiac catheterization studies. All patients had preoperative ejection fraction!50% (46 G 5%, range 31e50%), determined by echocardiography. The selection of LVEF % 50% as the cut-off point between normal and depressed LV function was based on Veterans Administration Co-operative Study on valvular heart disease. 9 The underlying cause of MR was myxomatous mitral valve disease (floppy mitral valve) in 24 patients, endocarditis in 4 and degenerative valves with ruptured chordae tendineae in 17. Twenty-seven patients (19 mene8 women, aged 62 G 10 years) ( group) underwent (according to the Carpentier type reconstruction 10,11 ) and a rigid Carpentier annular ring was inserted in 16 of them (Table 2). Eighteen patients (8 mene10 women, aged 60 G 12 years) ( group) underwent a conventional without preservation of papillary muscles and a low profile mechanical disc valve was implanted in all of them (Bjork-Shiley in 15 patients and St. Jude in 3). Patients in the 2 groups had similar age and degree of preoperative MR assessed by echocardiography and cardiac catheterization (Table 1). The decision to replace or to repair the valve was made on the table by the surgeon based on the valve anatomy. All patients were operated at the same center (Hammersmith Hospital, London, UK) by the same group of surgeons. Table 1 Preoperative patient characteristics Group A () Group B () No Age (years) 62 G G 12 Sex 19 mene8 women 8 mene10 women MR severity(median) 3/4 3/4 Moderate 2/4 8 4 Mod. severe 3/4 8 9 Severe 4/ Underlying disease Floppy MV 16 8 Flail MV 11 6 Endocarditis 0 4 Leaflets involved Posterior 21 9 Anterior 2 3 Both 4 6 SR/AF/paced 16/10/1 11/7/0, mitral valve repair;, mitral valve replacement; MR, mitral regurgitation; MV, mitral valve; SR, sinus rhythm; AF, atrial fibrillation.

3 vs in depressed LV function 437 Table 2 Group A patients characteristics regarding ring insertion Age (years) Leaflets involved Degree of MR AF Ring (N Z 16) 61 G 8 Posterior: 13 Moderate 2/4: 5 6 Anterior: 1 Mod. severe 3/4: 6 Both: 2 Severe 4/4:5 No ring (N Z 11) 63 G 12 Posterior: 8 Moderate 2/4: 3 10 Anterior: 1 Mod. severe 3/4: 2 Both: 2 Severe 4/4: 6 Follow-up The mean follow-up period was 6 G 3 years in all patients and was divided in 3 consecutive time periods: 6e18 months after surgery (FU1), 18e36 months (FU2) and O36 months (FU3). All patients were evaluated at the outpatient clinic yearly. Echocardiography All patients were evaluated with transthoracic and transoesophageal echocardiography, within 5 months before surgery. Transthoracic echocardiography was repeated within 3 months after surgery and on an annual base during the follow-up (FU) period. Examinations were performed in the left lateral decubitus position. LV systolic function was estimated from LV end-diastolic and end-systolic diameters (LVEDD, LVESD), fractional shortening (FS), ejection fraction (EF) and velocity time integral of LV outflow track (VTI) with Pulse wave Doppler. EF was calculated using the modified Simpson s method. The size of the left atrium (LA) was also measured and pulmonary artery systolic pressure (PASP) was estimated from tricuspid regurgitation. Mitral regurgitation was evaluated semi-quantitatively by color Doppler imaging at transthoracic and transoesophageal echocardiography and was graded as follows: 1 Z mild, 2 Z moderate, 3 Z moderately severe, 4 Z severe. Table 3 Postoperative patients characteristics p FU time (years) 6 G 3 6G 4 NS Deaths 5 6 NS Re-operation 2 1 NS MR increase a 2 1 NS New AF 3 4 NS a MR increase is defined as an increase of MR degree from 1/4 to 2/4. Statistics Statistical analysis was performed using the Statistical Package for the Social Sciences (SPSS) software. 12 Results were expressed as mean values G SD. Normal distribution of the echocardiographic indices was checked with Kolmogorove Smirnov test. Due to the fact that some measured data were skewed, analysis of the overall differences between subgroups was performed using the non-parametric ManneWhitney test or Kruskalle Wallis test for multiple comparisons. Paired analysis of each variable within the 2 groups was performed using the non-parametric Wilcoxon test or Friedman test for multiple comparisons. A p value!0.05 was considered significant. Results Clinical characteristics of the study population Patients clinical characteristics are presented in Table 1. No patient had any residual mitral regurgitation of any clinical significance at the first postoperative study. In the group, 5 patients were lost within the first year of FU and they were not included in the analysis of the data during FU period. In the group, 2 patients died 2 and 3 months, respectively, following surgery and 3 other were lost within the first year of FU and so the data of all 5 patients in this group were not included in the analysis of the data during FU period. Thus, of the 45 patients studied pre- and immediately postoperatively, 35 patients completed the FU3 period (O36 months) (22 in the group and 13 in the group). In-group analysis Overall changes of the echocardiographic indices postoperatively and during FU are presented in Table 4.

4 438 N. Kouris et al. Table 4 Changes of the echocardiographic indices postoperatively and during follow-up Pre-op Post-op FU1 FU2 FU3 Pre-op Post-op FU1 FU2 FU3 LVEDD (mm) 61 G 6 53G 6* 52 G 6 50G 7 51G 9 59G 7 55G 8* 55 G 8 57G 8 59G 9x LVESD (mm) 43 G 4 39G 5* 38 G 7 35G 6 37G 8 42G 5 41G 8 41G 8 43G 9 44G 10 FS (%) 28 G 4 27G 5 29G 6 30G 5 29G 8 28G 4 25G 5x 25 G 6 25G 6 24G 9 EF (%) 48 G 6 46G 7 48G G 9 48G G 6 42G 9{ 43 G G G 14 VTI (cm) 13 G 3 15G 2* 15 G 2 15G 2 16G 2 13G 3 14G 2 14G 3 13G 4 14G 3 LA (mm) 56 G G 9* 49 G G 9 52G 9 53G G G G G 13 PASP (mmhg) 26 G 5 26G 6 28G 7 28G 6 31G G 7 30G 7 32G 9 35G 9U 40 G 10U Values are expressed as mean G SD. FU1: follow-up 6e18 months, FU2: 18e36 months, FU3: O36 months. LVEDD, left ventricular end-diastolic diameter; LVESD, left ventricular end-systolic diameter; FS, fractional shortening; EF, ejection fraction; VTI, velocity time integral at left ventricular outflow tract; LA, left atrium; PASP, pulmonary artery systolic pressure. *p! 0.05 between pre- and postoperative values. xp! 0.02 between pre- and postoperative values and between post- and FU3 values. {p! 0.03 between pre- and postoperative values. Up! 0.05 between post- and FU2 and FU3 values. Values not indicated were NS (see text). Patients in group demonstrated a decrease of LVEDD from 61 G 6 mm preoperatively to 53 G 6 mm early postoperatively (p! 0.001), approaching normal values. The improvement of LVEDD remained unchanged throughout FU (Fig. 1). LVESD was also reduced from 43 G 4mm preoperatively to 39 G 5 mm early postoperatively (p Z 0.002), which was preserved during FU showing a trend for a further decrease (Fig. 2). FS and EF showed a mild deterioration from pre- to postoperative value (28 G 4% / 27 G 5%, p Z 0.2; 48 G 6% / 46 G 7%, p Z 0.25, respectively), but during FU, both indices showed a trend to improve (Fig. 3). Conversely, VTI showed an improvement LVEDD (mm) pre-op Left Ventricular End-Diastolic Diameter post-op FU 1 Time FU 2 FU 3 OPER Figure 1 Changes in left ventricular end-diastolic diameter from preoperative value through follow-up time. p 1 : difference between pre- and postoperative value in each group (in-group analysis), p 2 : difference between postoperative and FU3 value in group B (ingroup analysis), p 3 : difference in FU2 and FU3 values between the 2 groups (between-groups analysis). from 13 G 3 cm preoperatively to 15 G 2 cm early postoperatively, (p! 0.05), which was preserved during FU (Fig. 4). The LA size was reduced after surgery (56 G 10 mm / 50 G 9mm,p Z 0.001) and remained unchanged during FU. Finally, PASP was similar preoperatively, postoperatively and during FU (26 G 5mmHg/ 26 G 6mmHg/ 31 G 10 mmhg, p Z NS). In the subgroup of patients there were no differences in LV diameters and EF during FU between patients with or without an annular ring after surgical repair of the mitral valve. However, a borderline increase in FS and EF (p Z and p Z 0.05, respectively) was noted at FU1, in patients without an annular ring, compared to those LVESD (mm) pre-op Left Ventricular End-Systolic Diameter post-op FU 1 Time FU 2 FU 3 OPER Figure 2 Changes in left ventricular end-systolic diameter from preoperative value through follow-up time. p 1, p 2 : differences between pre- and postoperative value in and group, respectively (in-group analysis) p 3 : difference in FU2 and FU3 values between the 2 groups (between-groups analysis).

5 vs in depressed LV function 439 EF (%) with an annular ring implanted, but this difference was not evident in FU2 and FU3. In the group, LVEDD showed an early postoperative decrease, compared to its preoperative value (59 G 7 mm versus 55 G 8mm, p! 0.05). Conversely, LVEDD increased at 36 months of FU (post-op versus FU3 value: 55 G 8 mm versus 59 G 9mm,p Z 0.016, Fig. 1). LVESD remained high early postoperatively (Fig. 2), resulting in a significant decrease of FS and EF (pre-op / post-op value: 28 G 4% / 25 G 5%, p! 0.02, 47 G 6% / 42 G 9%, p! 0.03, respectively). The reduction in VTI (cm) pre-op pre-op post-op Velocity Time Integral post-op Ejection Fraction FU 1 Time FU 1 Time FU 2 FU 2 FU 3 FU 3 OPER OPER Figure 4 Changes in velocity time integral from preoperative value through follow-up time. p: difference between pre- and postoperative value in group (in-group analysis). All other differences were NS. Figure 3 Changes in left ventricular ejection fraction from preoperative value through follow-up time. p 1, p 2 : differences between pre- and postoperative value in and group, respectively (in-group analysis) p 3 : difference in FU2 and FU3 values between the 2 groups (between-groups analysis). FS and EF further increased at 36 months of FU (Fig. 3). VTI and LA size remained practically unchanged. PASP did not change significantly after surgery (28 G 7 mmhg / 30 G 7 mmhg, p Z NS), but at FU3 it increased from the postoperative value (30 G 7 mmhg / 40 G 10 mmhg, p Z 0.005). Finally, a modest correlation was found in both groups, between preoperative and postoperative LVEF (r Z 0.40). Between-groups analysis Patients in the 2 groups did not show any difference in any echocardiographic parameter preoperatively, as well as postoperatively. During FU1, no difference was found in any parameter, but at FU2 patients in group compared to patients in group demonstrated lower LVEDD (50 G 7 mm versus 59 G 8 mm, p! 0.05), lower LVESD (35 G 6 mm versus 43 G 9mm, p! 0.05), higher FS (30 G 5 mm versus 25 G 6 mm, p Z 0.07) and EF (50 G 9 mm versus 42 G 11 mm, p Z 0.07), smaller LA (51 G 9 mm versus 61 G 11 mm, p! 0.05), lower PASP (28 G 6 mmhg versus 35 G 9 mmhg, p! 0.05) and similar VTI (15 G 2 mm versus 13 G 4 mm, p Z 0.3). Finally, similar differences were observed between patients in the and patients in the group during FU3 (Figs. 1e4). Follow-up In group, five patients died at 5 G 1 years after surgery. All patients who died had completed the FU3 period, so their data were included in the analysis. Two other patients underwent due to failure (1 and 2 years after surgery, respectively). Two more patients demonstrated a progressive increase of mitral regurgitation during the FU period, not requiring surgical intervention. In the remaining 18 patients with, the mild residual MR observed early postoperatively, remained unchanged throughout FU period. Three patients developed atrial fibrillation (AF) during FU. None of the patients developed clinical or echocardiographic signs suggestive of coronary artery disease (akinesis or scar). Also, no perioperative myocardial infarction was found in the group. In the group, 2 patients died during early postoperative period (!3 months) and their data were not included in the analysis. Four other patients died at 7 G 4 years having completed the FU3 period, so their data were analyzed. Additionally, 1 patient was re-operated due to prosthetic valve endocarditis and four patients

6 440 N. Kouris et al. developed AF (2 permanent, 2 paroxysmal) (Group A versus Group B p Z NS, Table 3). Occurrence of AF did not differ between the 2 groups. Furthermore, in the group the mitral prosthesis remained well functioning with the pressure half time remaining unchanged throughout the FU period (PHT post-op: 94 G 35 ms, FU1: 105 G 30 ms, FU2: 88 G 32 ms, FU3: 82 G 27 ms, p Z NS). Finally, only 1 patient demonstrated increase of MR during FU period, not requiring surgical intervention, while in the rest of patients the mild residual MR remained unchanged. Thus, there was no significant difference between the 2 groups in the number of patients with deterioration of MR during FU (Table 3). Discussion Degenerative mitral valve disease is currently the most common cause of mitral regurgitation in Europe. 3 Mitral regurgitation leads to chronic volume overload of the left ventricle, progressively leading to LV dysfunction. 6 The regurgitant volume, ejected into the low-resistance left atrial chamber during systole, increases the total stroke volume and the EF. Since the LVEF, in the presence of severe MR, is often supranormal, the slightest reduction in EF is synonymous to significant LV dysfunction. Myocardial failure is also an important postoperative complication and it is responsible for the majority of postoperative cardiac related mortality and morbidity. 8 Many reports have shown that is superior to, as far as preservation of LV function is concerned. 1e4,13 To our knowledge, there have been no reports on the effects of mitral valve replacement versus repair on an already impaired LV function prior to valve surgery for isolated MR. In our study, LVEDD was significantly reduced in both groups postoperatively. This was an expected finding, since the cause of LV volume overload was eliminated. 14 During FU however, while in patients LVEDD remained within normal limits, in the group it increased again, 3 years after surgery, reaching the preoperative values, without any significant residual MR. This finding could be explained by the fact that in without chordal preservation, LV remodeling alters the shape of the left ventricle toward a spherical geometry (decreased eccentricity index), whether in the LV shape is not affected. Previous reports support this finding, although FU period was shorter. 5,15 It should be also noted that during FU, no perioperative acute myocardial infarction, which develops more frequently during, 16 was found in our group. Consequently, at 6 years FU, patients with demonstrated a lower FS and EF than patients with, compared to the early postoperative study. A possible explanation for these alterations is based upon the aforementioned changes in LV geometry. It has been proposed that, despite expected increase in LV afterload caused by the competent mitral valve, in as well as in with chordal preservation, LV afterload decreases after mitral surgery. 17 Preservation of the subvalvular apparatus in these techniques maintains LV geometry and allows a reduction of LV radius, leading to a reduction in wall stress (LV afterload), according to the Laplace equation. This LV afterload reduction is even more beneficial in patients with preoperatively reduced LV contractility. 6 Conversely, endsystolic wall stress is increased after without chordal preservation due to the loss of chordal support and LV end-systolic volume fails to decrease. 18 Ren and colleagues 15 suggest that preservation of LVEF in and in with chordal preservation is not caused by a decrease in endsystolic volume; the decrease in end-systolic volume is the result of a preserved EF (due to the maintenance of the functional components of the subvalvular apparatus), even though there is a decrease in end-diastolic volume. 15 Our results are in agreement with other reports that showed preservation (not improvement) of LVEF after 1,6,15 and deterioration after 1,13,15 and this preservation is maintained during a long period of time postoperatively after, while it further deteriorates after. The decrease in FS and EF that was noted in both groups at the early postoperative period, is consistent with the reports of Enriquez-Sarano et al., who reported this finding almost 10 years ago, in patients with preoperatively normal systolic function. 2 The weak correlation that was also found in both groups, between preoperative and postoperative LVEF (r Z 0.40), is consistent with previous reports. 19 The data of this cohort demonstrate that patients with MR, who have developed LV dysfunction because they were not operated early enough during the natural history of their valve disease, can benefit from valve reconstruction. However, neither with nor with a normalization of LVEF with mean values O55% could be obtained. Incidence of atrial fibrillation Incidence of AF did not differ between the 2 groups neither preoperatively, nor postoperatively or during FU. Because of the small number of patients, we could not demonstrate whether AF played any role in LV remodeling, although such

7 vs in depressed LV function 441 a role seems inexplicit to influence the results of one surgical technique over the other. This is supported by Lim et al., 20 who suggested that AF did not affect early outcome of. Ring versus no ring Patients who underwent with concomitant annular ring insertion did not show any significant difference in postoperative LV function, compared to those without ring implantation. The decision whether a ring should be inserted was based upon the surgeon s choice for best anatomical correction of the responsible leaflet, since the 2 subgroups with and without ring were identical, concerning the affected leaflet and the degree of MR preoperatively. The use of annular ring during is controversial and not all surgeons do recommend its implantation, since it improves the results of but, on the other hand, it increases the frequency of systolic anterior motion (SAM). 21 Moreover, the effects of rigid or flexible rings on LV function are also controversial. David et al. 22 reported better LV function after insertion of flexible ring, while Castro et al. did not show any significant difference between the 2 rings. 23 Study limitations It is possible that due to the relatively small number of patients involved, some of our results might have been affected, particularly in the subgroup analysis. The patient s surgical procedure was not randomized preoperatively and was determined by the surgeon at the time of the operation. However, since a randomized trial will probably never be performed, the only acceptable method of comparison of the 2 surgical procedures is to adjust the baseline preoperative parameters. We reported a significant increase of LVEDD in group during 6 years FU. However, subclinical coronary artery disease may not be excluded, as coronary angiography was not performed in any patient postoperatively. The paradoxic septal motion associated with cardiac surgery might raise concern about the use of echocardiography for postoperative assessment of LVEF. This, however, has been attributed to a translational movement rather than a regional wall motion abnormality and it does not impair the ability to assess LV function by echocardiography. 24 Finally, we did not perform any formal quantitation of MR due to the absence of any standardized criteria at the time of the study. Conclusion In this study we report that during a 6-year followup, patients with chronic degenerative MR and LV dysfunction show further deterioration of LV function after. Conversely, appear to better preserve the overall LV function. Mitral valve repair should therefore be the surgical procedure of choice, not only for the lower mortality during the operation itself, but also for the better preservation of LV function in the long term and the level of ejection fraction should not be a reason for denying the benefits of repair to patients with MR. Nevertheless, although seems to preserve LV function, it rarely achieves complete normalization of LVEF and therefore early surgery should be performed before these patients develop LV dysfunction. References 1. Goldman ME, Mora F, Guarino T, Fuster V, Mindich BP. Mitral valvuloplasty is superior to valve replacement for preservation of left ventricular function: an intraoperative twodimensional echocardiographic study. J Am Coll Cardiol 1987;10:568e Enriquez-Sarano M, Schaff HV, Orszulak TA, Tajik AJ, Bailey KR, Frye RL. Valve repair improves the outcome of surgery for mitral regurgitation. A multivariate analysis. Circulation 1995;91:1022e8. 3. Lee EM, Shapiro LM, Wells FC. Superiority of mitral valve repair in surgery for degenerative mitral regurgitation. Eur Heart J 1997;18:655e Tischler MD, Cooper KA, Rowen M, LeWinter MM. Mitral valve replacement versus mitral valve repair. A Doppler and quantitative stress echocardiographic study. Circulation 1994;89:132e7. 5. Enriquez-Sarano M, Tajik AJ, Schaff HV, Orszulak TA, McGoon MD, Bailey KR, et al. Echocardiographic prediction of left ventricular function after correction of mitral regurgitation: results and clinical implications. J Am Coll Cardiol 1994;24:1536e de Varennes B, Haichin R. Impact of preoperative left ventricular ejection fraction on postoperative left ventricular remodeling after mitral valve repair for degenerative disease. J Heart Valve Dis 2000;9:313e Enriquez-Sarano M, Tajik AJ, Schaff HV, Orszulak TA, Bailey KR, Frye RL. Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation. Circulation 1994;90:830e7. 8. Enriquez-Sarano M, Schaff HV, Orszulak TA, Tajik AJ, Bailey KR, Frye RL. Congestive heart failure after surgical correction of mitral regurgitation. A long term study. Circulation 1995;92:2496e Crawford MH, Souchek J, Oprian CA, Miller DC, Rahimtoola S, Giacomini JC, et al. Determinants of survival and left ventricular performance after mitral valve replacement: Department of Veterans Affairs Cooperative Study on Valvular Heart Disease. Circulation 1990;81: 1173e81.

8 442 N. Kouris et al. 10. Carpentier A, Relland J, Deloche A, Fabiani JN, D Allaines C, Blondeau P, et al. Conservative management of the prolapsed mitral valve. Ann Thorac Surg 1978;26: 294e Carpentier A. Cardiac valve surgery e the French Correction. J Thorac Cardiovasc Surg 1983;86:323e SPSS. Statistical Package for the Social Sciences. Windows version, release Chicago: SPSS Inc; Huikuri H. Effect of mitral valve replacement on left ventricular function in mitral regurgitation. Br Heart J 1983;49: Tischler MD, Cooper KA, Battle RW, Leavitt BJ. Effect of mitral valve repair for mitral valve prolapse on regression of left ventricular mass. Am J Cardiol 1992;70:1216e Ren J, Aksut S, Lighty GW, Vigilante GJ, Sink JD, Segal BL, et al. Mitral valve repair is superior to valve replacement for the early preservation of cardiac function: relation of ventricular geometry to function. Am Heart J 1996;131: 974e Obarski TP, Loop FD, Cosgrove DM, Lytle BW, Stewart WJ. Frequency of acute myocardial infarction in valve repairs versus valve replacement for pure mitral regurgitation. Am J Cardiol 1990;65:887e Okita Y, Miki S, Veda Y, Tahata T, Sakai T, Matsuyama K. Comparative evaluation of left ventricular performance after mitral valve repair or valve replacement with or without chordal preservation. J Heart Valve Dis 1993;99: 228e Rozich TD, Carabello BA, Usher BW, Kratz JM, Bell AE, Zile MR. Mitral valve replacement with or without chordal preservation in patients with chronic mitral regurgitation. Circulation 1992;86:1718e Matsumura T, Ohtaki E, Tanaka K, Misu K, Tobaru T, Asano R, et al. Echocardiographic prediction of left ventricular dysfunction after mitral valve repair for mitral regurgitation as an indicator to decide the optimal timing of repair. JAm Coll Cardiol 2003;42:464e Lim E, Barlow CW, Hosseinpour AR, Wisbey C, Wilson K, Pidgeon W, et al. Influence of atrial fibrillation on outcome following mitral valve repair. Circulation 2001;104 (12 Suppl.1):I59e Bisbos AD, Spanos PK. Surgical correction of mitral valve regurgitation. Hell J Cardiol 2003;44:469e David TE, Komeda M, Pollick C, Burns RJ. Mitral valve annuloplasty: the effect of the type on left ventricular function. Ann Thorac Surg 1989;47: Castro LJ, Moon MR, Rayhill SC, Niczypornk MA, Ingels Jr NB, Daughters 3rd GT, et al. Annuloplasty with flexible or rigid ring does not alter left ventricular systolic performance, energetics or ventricularearterial coupling in conscious, closed-chest dogs. J Thorac Cardiovasc Surg 1993;105: Lehmann KG, Lee FA, McKenzie WB, Barash PG, Prokop EK, Durkin MA, et al. Onset of altered interventricular septal motion during cardiac surgery: assessment by continuous intraoperative transesophageal echocardiography. Circulation 1990;82:1325e34.

Journal of the American College of Cardiology Vol. 42, No. 3, by the American College of Cardiology Foundation ISSN /03/$30.

Journal of the American College of Cardiology Vol. 42, No. 3, by the American College of Cardiology Foundation ISSN /03/$30. Journal of the American College of Cardiology Vol. 42, No. 3, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Inc. doi:10.1016/s0735-1097(03)00649-1

More information

Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention

Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention John N. Hamaty D.O. FACC, FACOI November 17 th 2017 I have no financial disclosures Primary Mitral

More information

LV geometric and functional changes in VHD: How to assess? Mi-Seung Shin M.D., Ph.D. Gachon University Gil Hospital

LV geometric and functional changes in VHD: How to assess? Mi-Seung Shin M.D., Ph.D. Gachon University Gil Hospital LV geometric and functional changes in VHD: How to assess? Mi-Seung Shin M.D., Ph.D. Gachon University Gil Hospital LV inflow across MV LV LV outflow across AV LV LV geometric changes Pressure overload

More information

Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease

Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease TIRONE E. DAVID, MD ; SEMIN THORAC CARDIOVASC SURG 19:116-120c 2007 ELSEVIER INC. PRESENTED BY INTERN 許士盟 Mitral valve

More information

Influence of Atrial Fibrillation on Outcome Following Mitral Valve Repair

Influence of Atrial Fibrillation on Outcome Following Mitral Valve Repair Influence of Atrial Fibrillation on Outcome Following Mitral Valve Repair Eric Lim, MBChB, MRCS; Clifford W. Barlow, DPhil, FRCS; A. Reza Hosseinpour, FRCS; Christopher Wisbey, BA; Kate Wilson, RN, BSc;

More information

What is the Role of Surgical Repair in 2012

What is the Role of Surgical Repair in 2012 What is the Role of Surgical Repair in 2012 The Long-Term Results of Surgery Raphael Rosenhek Department of Cardiology Medical University of Vienna European Society of Cardiology 2012 Munich, August 27th

More information

Mitral Valve Disease, When to Intervene

Mitral Valve Disease, When to Intervene Mitral Valve Disease, When to Intervene Swedish Heart and Vascular Institute Ming Zhang MD PhD Interventional Cardiology Structure Heart Disease Conflict of Interest None Current ACC/AHA guideline Stages

More information

Surgery for Valvular Heart Disease. Very Long-Term Survival and Durability of Mitral Valve Repair for Mitral Valve Prolapse

Surgery for Valvular Heart Disease. Very Long-Term Survival and Durability of Mitral Valve Repair for Mitral Valve Prolapse Surgery for Valvular Heart Disease Very Long-Term Survival and Durability of Mitral Valve Repair for Mitral Valve Prolapse Dania Mohty, MD; Thomas A. Orszulak, MD; Hartzell V. Schaff, MD; Jean-Francois

More information

Ann Thorac Cardiovasc Surg 2015; 21: Online April 18, 2014 doi: /atcs.oa Original Article

Ann Thorac Cardiovasc Surg 2015; 21: Online April 18, 2014 doi: /atcs.oa Original Article Ann Thorac Cardiovasc Surg 2015; 21: 53 58 Online April 18, 2014 doi: 10.5761/atcs.oa.13-00364 Original Article The Impact of Preoperative and Postoperative Pulmonary Hypertension on Long-Term Surgical

More information

The New England Journal of Medicine. Clinical Practice. Diagnosis. Echocardiography

The New England Journal of Medicine. Clinical Practice. Diagnosis. Echocardiography Clinical Practice This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines,

More information

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM The Patient with Aortic Stenosis and Mitral Regurgitation Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM Aortic Stenosis + Mitral Regurgitation?

More information

Χειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας

Χειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας Χειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας Dr Χρήστος ΑΛΕΞΙΟΥ MD, PhD, FRCS(Glasgow), FRCS(CTh), CCST(UK) Consultant Cardiothoracic Surgeon Normal Mitral Valve Function Mitral Regurgitation

More information

Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement?

Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Original Article Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Hiroaki Sakamoto, MD, PhD, and Yasunori Watanabe, MD, PhD Background: Recently, some articles

More information

Primary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017

Primary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017 Disclosures: GE stock, Primary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017 Athena Poppas, MD FACC Past ACC Scientific Sessions Chair, ACC Board

More information

Overview of Surgical Approach to Mitral Valve Disease : Why Repair? Steven F. Bolling, MD Cardiac Surgery University of Michigan

Overview of Surgical Approach to Mitral Valve Disease : Why Repair? Steven F. Bolling, MD Cardiac Surgery University of Michigan Overview of Surgical Approach to Mitral Valve Disease : Why Repair? Steven F. Bolling, MD Cardiac Surgery University of Michigan Degenerative MR is not Functional MR 2o - Functional MR : Ventricular Problem!!

More information

Load and Function - Valvular Heart Disease. Tom Marwick, Cardiovascular Imaging Cleveland Clinic

Load and Function - Valvular Heart Disease. Tom Marwick, Cardiovascular Imaging Cleveland Clinic Load and Function - Valvular Heart Disease Tom Marwick, Cardiovascular Imaging Cleveland Clinic Indications for surgery in common valve lesions Risks Operative mortality Failed repair - to MVR Operative

More information

Mitral valve surgery has changed considerably in the past decades and is now indicated

Mitral valve surgery has changed considerably in the past decades and is now indicated Valve disease TIMING OF MITRAL VALVE SURGERY c POOR Correspondence to: Dr Maurice Enriquez-Sarano, Mayo Clinic, 2 First Street SW, Rochester, MN 5595, USA; sarano.maurice@mayo.edu Copyright 22 Mayo Foundation

More information

Development of tricuspid regurgitation late after left-sided valve surgery: A single-center experience with long-term echocardiographic examinations

Development of tricuspid regurgitation late after left-sided valve surgery: A single-center experience with long-term echocardiographic examinations Imaging and Diagnostic Testing Development of tricuspid regurgitation late after left-sided valve surgery: A single-center experience with long-term echocardiographic examinations Jae-Jin Kwak, MD, a Yong-Jin

More information

Recurrent mitral regurgitation after repair: Should the mitral valve be re-repaired?

Recurrent mitral regurgitation after repair: Should the mitral valve be re-repaired? Surgery for Acquired Cardiovascular Disease Recurrent mitral regurgitation after repair: Should the mitral valve be re-repaired? Rakesh M. Suri, MD, DPhil, Hartzell V. Schaff, MD, Joseph A. Dearani, MD,

More information

The use of mitral valve (MV) repair to correct mitral

The use of mitral valve (MV) repair to correct mitral Outcomes and Long-Term Survival for Patients Undergoing Repair Versus Effect of Age and Concomitant Coronary Artery Bypass Grafting Vinod H. Thourani, MD; William S. Weintraub, MD; Robert A. Guyton, MD;

More information

Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat

Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat Innovative Procedures, Devices & State of the Art Care for Arrhythmias, Heart Failure & Structural Heart Disease October 8-10,

More information

Which Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should Be Surgically Treated?

Which Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should Be Surgically Treated? Ann Thorac Cardiovasc Surg 2013; 19: 428 434 Online January 31, 2013 doi: 10.5761/atcs.oa.12.01929 Original Article Which Type of Secondary Tricuspid Regurgitation Accompanying Mitral Valve Disease Should

More information

Echocardiographic variables associated with mitral regurgitation after aortic valve replacement for aortic valve stenosis

Echocardiographic variables associated with mitral regurgitation after aortic valve replacement for aortic valve stenosis The Egyptian Heart Journal (2013) 65, 135 139 Egyptian Society of Cardiology The Egyptian Heart Journal www.elsevier.com/locate/ehj www.sciencedirect.com ORIGINAL ARTICLE Echocardiographic variables associated

More information

Long-Term Assessment of Mitral Valve Reconstruction With Resection of the Leaflets: Triangular and Quadrangular Resection

Long-Term Assessment of Mitral Valve Reconstruction With Resection of the Leaflets: Triangular and Quadrangular Resection Long-Term Assessment of Mitral Valve Reconstruction With Resection of the Leaflets: Triangular and Quadrangular Resection Yoshimasa Sakamoto, MD, Kazuhiro Hashimoto, MD, Hiroshi Okuyama, MD, Shinichi Ishii,

More information

The benefits of mitral valve reconstruction for operative

The benefits of mitral valve reconstruction for operative Prophylactic Mitral Reconstruction for Mitral Regurgitation Iva A. Smolens, MD, Francis D. Pagani, MD, PhD, G. Michael Deeb, MD, Richard L. Prager, MD, Seema S. Sonnad, PhD, and Steven F. Bolling, MD Section

More information

A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision

A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision Prof. Pino Fundarò, MD Niguarda Hospital Milan, Italy Introduction

More information

Late secondary TR after left sided heart disease correction: is it predictibale and preventable

Late secondary TR after left sided heart disease correction: is it predictibale and preventable Late secondary TR after left sided heart disease correction: is it predictibale and preventable Gilles D. Dreyfus Professor of Cardiothoracic surgery Nath J, et al. JACC 2004 PREDICT Incidence of secondary

More information

Valve Analysis and Pathoanatomy: THE MITRAL VALVE

Valve Analysis and Pathoanatomy: THE MITRAL VALVE : THE MITRAL VALVE Marc R. Moon, M.D. John M. Shoenberg Chair in CV Disease Chief, Cardiac Surgery Washington University School of Medicine, St. Louis, MO Secretary, American Association for Thoracic Surgery

More information

Asymptomatic Valvular Disease:

Asymptomatic Valvular Disease: Asymptomatic Valvular Disease: Can Echocardiography Help You Decide When to Intervene? Neil J. Weissman, MD MedStar Health Research Inst at MedStar Washington Hospital Center & Professor of Medicine Georgetown

More information

Organic mitral regurgitation

Organic mitral regurgitation The best in heart valve disease Organic mitral regurgitation Ewa Szymczyk Department of Cardiology Medical University of Lodz, Poland I have nothing to declare Organic mitral regurgitation leaflet abnormality

More information

Primary Mitral Regurgitation

Primary Mitral Regurgitation EURO VALVE Madrid News from Valves Guidelines 2012: What s new and Why? Primary Mitral Regurgitation Luc A. Pierard, MD, PhD Professor of Medicine Head of the Department of Cardiology Heart Valve Clinic,

More information

The production of murmurs is due to 3 main factors:

The production of murmurs is due to 3 main factors: Heart murmurs The production of murmurs is due to 3 main factors: high blood flow rate through normal or abnormal orifices forward flow through a narrowed or irregular orifice into a dilated vessel or

More information

Ischemic Mitral Valve Disease: Repair, Replace or Ignore?

Ischemic Mitral Valve Disease: Repair, Replace or Ignore? Ischemic Mitral Valve Disease: Repair, Replace or Ignore? Fabio B. Jatene Full Professor of Cardiovascular Surgery, Medical School, University of São Paulo, Brazil DISCLOSURE I have no financial relationship

More information

Quality Outcomes Mitral Valve Repair

Quality Outcomes Mitral Valve Repair Quality Outcomes Mitral Valve Repair Moving Beyond Reoperation Rakesh M. Suri, D.Phil. Professor of Surgery 2015 MFMER 3431548-1 Disclosure Mayo Clinic Division of Cardiovascular Surgery Research funding

More information

Mitral Valve prolapse: What s new? Which indications of early surgery? Input of new 2017 ESC/EACTS guidelines. Christophe Tribouilloy Amiens, France

Mitral Valve prolapse: What s new? Which indications of early surgery? Input of new 2017 ESC/EACTS guidelines. Christophe Tribouilloy Amiens, France Mitral Valve prolapse: What s new? Which indications of early surgery? Input of new 2017 ESC/EACTS guidelines Christophe Tribouilloy Amiens, France I have no financial relationships to disclose related

More information

Les valvulopathies en sourdine: la valve mitrale Quoi faire devant une régurgitation mitrale sévère asymptomatique de type dégénérative?

Les valvulopathies en sourdine: la valve mitrale Quoi faire devant une régurgitation mitrale sévère asymptomatique de type dégénérative? Réunion d automne de la SSC à Lucerne le 24.11.2011 Incertitudes dans le travail cardiologique quotidien Les valvulopathies en sourdine: la valve mitrale Quoi faire devant une régurgitation mitrale sévère

More information

PROSTHETIC VALVE BOARD REVIEW

PROSTHETIC VALVE BOARD REVIEW PROSTHETIC VALVE BOARD REVIEW The correct answer D This two chamber view shows a porcine mitral prosthesis with the typical appearance of the struts although the leaflets are not well seen. The valve

More information

Mitral valve repair is established as the procedure of choice for

Mitral valve repair is established as the procedure of choice for Determinants and assessment of regurgitation after mitral valve repair Eric Lim, MB, ChB, MRCS a Ziad A. Ali, MB, ChB a Clifford W. Barlow, DPhil, FRCS (CTh) a A. Reza Hosseinpour, FRCS a Christopher Wisbey,

More information

ECHOCARDIOGRAPHY DATA REPORT FORM

ECHOCARDIOGRAPHY DATA REPORT FORM Patient ID Patient Study ID AVM - - Date of form completion / / 20 Initials of person completing the form mm dd yyyy Study period Preoperative Postoperative Operative 6-month f/u 1-year f/u 2-year f/u

More information

Percutaneous Mitral Valve Repair

Percutaneous Mitral Valve Repair Indiana Chapter of ACC November 15 th,2008 Percutaneous Mitral Valve Repair James B Hermiller, MD, FACC The Care Group, LLC St Vincent Hospital Indianapolis, IN Mechanisms of Mitral Regurgitation Mitral

More information

The risk-benefit ratio of mitral valve operation is

The risk-benefit ratio of mitral valve operation is Degenerative Mitral Regurgitation: When Should We Operate? Malcolm J. R. Dalrymple-Hay, PhD, Mark Bryant, Richard A. Jones, MRCP, Stephen M. Langley, FRCS, Steven A. Livesey, FRCS, and James L. Monro,

More information

The production of murmurs is due to 3 main factors:

The production of murmurs is due to 3 main factors: Heart murmurs The production of murmurs is due to 3 main factors: high blood flow rate through normal or abnormal orifices forward flow through a narrowed or irregular orifice into a dilated vessel or

More information

Clinical Outcome of Tricuspid Regurgitation. David Messika-Zeitoun

Clinical Outcome of Tricuspid Regurgitation. David Messika-Zeitoun Clinical Outcome of Tricuspid Regurgitation David Messika-Zeitoun I have financial relationships to disclose Consultant for: Edwards, Symetis and Valtech Tricuspid Regurgitation is a Common Finding Tricuspid

More information

Update on Mitral Repair in Dilated Cardiomyopathy

Update on Mitral Repair in Dilated Cardiomyopathy 396 Update on Mitral Repair in Dilated Cardiomyopathy Matthew A. Romano, M.D., and Steven F. Bolling, M.D. University of Michigan, Section of Cardiac Surgery, Ann Arbor, Michigan ABSTRACT Heart failure

More information

Chronic Primary Mitral Regurgitation

Chronic Primary Mitral Regurgitation Chronic Primary Mitral Regurgitation The Case For Early Surgical Intervention William K. Freeman, MD, FACC, FASE DISCLOSURES Relevant Financial Relationship(s) None Off Label Usage None Watchful Waiting......

More information

Echocardiographic Correlates of Pulmonary Artery Systolic Pressure

Echocardiographic Correlates of Pulmonary Artery Systolic Pressure Echocardiographic Correlates of Pulmonary Artery Systolic Pressure The Role of Left Ventricular Diastolic Function Yoram Agmon MD, Shemy Carasso MD, Diab Mutlak MD, Jonathan Lessick MD Dsc, Izhak Kehat

More information

Degenerative mitral valve disease is the leading cause of

Degenerative mitral valve disease is the leading cause of Recurrence of Mitral Valve Regurgitation After Mitral Valve Repair in Degenerative Valve Disease Willem Flameng, MD, PhD; Paul Herijgers, MD, PhD; Kris Bogaerts, MSc Background Durability assessment of

More information

Management of Tricuspid Regurgitation

Management of Tricuspid Regurgitation Management of Tricuspid Regurgitation Antonis A. Pitsis, FETCS, FESC Thessaloniki Heart Institute, St. Luke s Hospital, Thessaloniki, GREECE HEART FAILURE 2012 BELGRADE SERBIA Does Tricuspid Regurgitation

More information

Mitral valve repair is the gold standard to treat mitral regurgitation.

Mitral valve repair is the gold standard to treat mitral regurgitation. Papillary muscle repositioning for repair of anterior leaflet prolapse caused by chordal elongation Gilles D. Dreyfus, MD, PhD, FRCS, Olivio Souza Neto, MD, and Stéphane Aubert, MD, MSc Objective: Anterior

More information

Restoration of Sinus Rhythm by the Maze Procedure Halts Progression of Tricuspid Regurgitation After Mitral Surgery

Restoration of Sinus Rhythm by the Maze Procedure Halts Progression of Tricuspid Regurgitation After Mitral Surgery Restoration of Sinus Rhythm by the Maze Procedure Halts Progression of Tricuspid Regurgitation After Mitral Surgery John M. Stulak, MD,* Hartzell V. Schaff, MD, Joseph A. Dearani, MD, Thomas A. Orszulak,

More information

Echocardiographic changes after aortic valve replacement: Does the failure rate of mitral valve change? Original Article

Echocardiographic changes after aortic valve replacement: Does the failure rate of mitral valve change? Original Article Echocardiographic changes after aortic valve replacement: Does the failure rate of mitral valve change? Abstract Arezoo Khosravi (1), Hadi Sheykhloo (2), Reza Karbasi-Afshar (1), Amin Saburi (3) Original

More information

Repair or Replacement

Repair or Replacement Surgical intervention post MitraClip Device: Repair or Replacement Saudi Heart Association, February 21-24 Rüdiger Lange, MD, PhD Nicolo Piazza, MD, FRCPC, FESC German Heart Center, Munich, Germany Division

More information

Isolated Mitral Valve Repair in Patients With Depressed Left Ventricular Function

Isolated Mitral Valve Repair in Patients With Depressed Left Ventricular Function Isolated Mitral Valve Repair in Patients With Depressed Left Ventricular Function Ashish S. Shah, MD, Steven A. Hannish, MD, Carmelo A. Milano, MD, and Donald D. Glower, MD Department of General and Thoracic

More information

LV FUNCTION ASSESSMENT: WHAT IS BEYOND EJECTION FRACTION

LV FUNCTION ASSESSMENT: WHAT IS BEYOND EJECTION FRACTION LV FUNCTION ASSESSMENT: WHAT IS BEYOND EJECTION FRACTION Jamilah S AlRahimi Assistant Professor, KSU-HS Consultant Noninvasive Cardiology KFCC, MNGHA-WR Introduction LV function assessment in Heart Failure:

More information

Index. B B-type natriuretic peptide (BNP), 76

Index. B B-type natriuretic peptide (BNP), 76 Index A ACCESS-EU registry, 158 159 Acute kidney injury (AKI), 76, 88 Annular enlargement, RV, 177 178 Annuloplasty chordal cutting, 113 complete ring, 99 etiology-specific ring, 100 evolution, 98 flexible

More information

Appendix II: ECHOCARDIOGRAPHY ANALYSIS

Appendix II: ECHOCARDIOGRAPHY ANALYSIS Appendix II: ECHOCARDIOGRAPHY ANALYSIS Two-Dimensional (2D) imaging was performed using the Vivid 7 Advantage cardiovascular ultrasound system (GE Medical Systems, Milwaukee) with a frame rate of 400 frames

More information

TSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD

TSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD TSDA Boot Camp September 13-16, 2018 Introduction to Aortic Valve Surgery George L. Hicks, Jr., MD Aortic Valve Pathology and Treatment Valvular Aortic Stenosis in Adults Average Course (Post mortem data)

More information

Advanced Evaluation of Left Ventricular Function in Degenerative MR. Dr Julien Magne, PhD University of Liege, CHU Sart Tilman, Liege, Belgium

Advanced Evaluation of Left Ventricular Function in Degenerative MR. Dr Julien Magne, PhD University of Liege, CHU Sart Tilman, Liege, Belgium Advanced Evaluation of Left Ventricular Function in Degenerative MR Dr Julien Magne, PhD University of Liege, CHU Sart Tilman, Liege, Belgium Conflict of Interest Disclosure None Case Clinical data Previous

More information

Disclosure Statement of Financial Interest Saibal Kar, MD, FACC

Disclosure Statement of Financial Interest Saibal Kar, MD, FACC MitraClip Therapy Saibal Kar, MD, FACC, FAHA, FSCAI Director of Interventional Cardiac Research Program Director, Interventional Cardiology Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA

More information

The Edge-to-Edge Technique f For Barlow's Disease

The Edge-to-Edge Technique f For Barlow's Disease The Edge-to-Edge Technique f For Barlow's Disease Ottavio Alfieri, Michele De Bonis, Elisabetta Lapenna, Francesco Maisano, Lucia Torracca, Giovanni La Canna. Department of Cardiac Surgery, San Raffaele

More information

MITRAL VALVE PATHOLOGY WITH TRICUSPID REGURGITATION (AND PHT)

MITRAL VALVE PATHOLOGY WITH TRICUSPID REGURGITATION (AND PHT) UNIVERSITY OF PADUA, SCHOOL OF MEDICINE Department of Cardiac,Thoracic and Vascular Sciences Padua, Italy MITRAL VALVE PATHOLOGY WITH TRICUSPID REGURGITATION (AND PHT) Luigi P. Badano**, MD, PhD, FESC,

More information

Ioannis Alexanian, MD, PhD Department of Cardiology General Hospital of Chest Diseases Sotiria Athens

Ioannis Alexanian, MD, PhD Department of Cardiology General Hospital of Chest Diseases Sotiria Athens MITRAL REGURGITATION IN PATIENT WITH SEVERE AORTIC VALVE STENOSIS Ioannis Alexanian, MD, PhD Department of Cardiology General Hospital of Chest Diseases Sotiria Athens I HAVE NOTHING TO DECLARE Management

More information

When should we intervene surgically in pediatric patient with MR?

When should we intervene surgically in pediatric patient with MR? When should we intervene surgically in pediatric patient with MR? DR.SAUD A. BAHAIDARAH CONSULTANT, PEDIATRIC CARDIOLOGY ASSISTANT PROFESSOR OF PEDIATRICS HEAD OF CARDIOLOGY AND CARDIAC SURGERY UNIT KAUH

More information

Assessing the Impact on the Right Ventricle

Assessing the Impact on the Right Ventricle Advances in Tricuspid Regurgitation Congress of the European Society of Cardiology (ESC) Munich, August 25-29, 2012 Assessing the Impact on the Right Ventricle Stephan Rosenkranz, MD Clinic III for Internal

More information

Clinical material and methods. Fukui Cardiovascular Center, Fukui, Japan

Clinical material and methods. Fukui Cardiovascular Center, Fukui, Japan Mitral Valve Regurgitation after Atrial Septal Defect Repair in Adults Shohei Yoshida, Satoshi Numata, Yasushi Tsutsumi, Osamu Monta, Sachiko Yamazaki, Hiroyuki Seo, Takaaki Samura, Hirokazu Ohashi Fukui

More information

Management of HOCM: Non-Surgical Options

Management of HOCM: Non-Surgical Options Management of HOCM: Non-Surgical Options Howard C. Herrmann, MD, FACC, MSCAI John Bryfogle Professor of Cardiovascular Medicine and Surgery Health System Director for Interventional Cardiology Director,

More information

Exercise Pulmonary Hypertension predicts the Occurrence of Symptoms in Asymptomatic Degenerative Mitral Regurgitation

Exercise Pulmonary Hypertension predicts the Occurrence of Symptoms in Asymptomatic Degenerative Mitral Regurgitation Exercise Pulmonary Hypertension predicts the Occurrence of Symptoms in Asymptomatic Degenerative Mitral Regurgitation Julien Magne, PhD, Kim O Connor, MD, Giuseppe Romano, MD, Marie Moonen, MD, Luc A.

More information

Introduction. Aims. Keywords Mitral regurgitation Echocardiography Left ventricular dysfunction Surgery

Introduction. Aims. Keywords Mitral regurgitation Echocardiography Left ventricular dysfunction Surgery European Journal of Echocardiography (2011) 12, 702 710 doi:10.1093/ejechocard/jer128 Predicting left ventricular dysfunction after valve repair for mitral regurgitation due to leaflet prolapse: additive

More information

25 different brand names >44 different models Sizes mm

25 different brand names >44 different models Sizes mm Types of Prosthetic Valves BIOLOGIC STENTED Porcine xenograft Pericardial xenograft STENTLESS Porcine xenograft Pericardial xenograft Homograft (allograft) Autograft PERCUTANEOUS MECHANICAL Bileaflet Single

More information

Valve Repair for Mitral Regurgitation Caused by Isolated Prolapse of the Posterior Leaflet

Valve Repair for Mitral Regurgitation Caused by Isolated Prolapse of the Posterior Leaflet Valve Repair for Mitral Regurgitation Caused by Isolated Prolapse of the Posterior Leaflet Patrick Perier, MD, J/2rgen Stumpf, MD, Christian GStz, MD, Fitsoum Lakew, MD, Andr6 Schneider, MD, Bernd Clausnizer,

More information

Functional Anatomy of Mitral Regurgitation

Functional Anatomy of Mitral Regurgitation Journal of the American College of Cardiology Vol. 34, No. 4, 1999 1999 by the American College of Cardiology ISSN 0735-1097/99/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00314-9 Functional

More information

MR echo case. N.Koutsogiannis Department of Cardiology University Hospital Of Patras

MR echo case. N.Koutsogiannis Department of Cardiology University Hospital Of Patras MR echo case N.Koutsogiannis Department of Cardiology University Hospital Of Patras Case A 35 years old male came to the echo lab for a third opinion for his valvulopathy. He reports a long standing MR

More information

Echocardiography as a diagnostic and management tool in medical emergencies

Echocardiography as a diagnostic and management tool in medical emergencies Echocardiography as a diagnostic and management tool in medical emergencies Frank van der Heusen MD Department of Anesthesia and perioperative Care UCSF Medical Center Objective of this presentation Indications

More information

Outline 9/17/2016. Advances in Percutaneous Mitral Valve Repair and Replacement. Scope of the Problem and Guidelines

Outline 9/17/2016. Advances in Percutaneous Mitral Valve Repair and Replacement. Scope of the Problem and Guidelines Advances in Percutaneous Mitral Valve Repair and Replacement Scott M Lilly MD PhD, Interventional Cardiology The Ohio State University Contemporary Multidisciplinary Cardiovascular Conference Orlando,

More information

Ischemic Mitral Regurgitation

Ischemic Mitral Regurgitation Ischemic Mitral Regurgitation 1 / 6 2 / 6 3 / 6 Ischemic Mitral Regurgitation Background Myocardial infarction (MI) can directly cause (IMR), which has been touted as an indicator of poor prognosis in

More information

Mitral valve regurgitation is a powerful factor of left ventricular hypertrophy

Mitral valve regurgitation is a powerful factor of left ventricular hypertrophy Original article Mitral valve regurgitation is a powerful factor of left ventricular hypertrophy Ewa Szymczyk, Karina Wierzbowska Drabik, Jarosław Drożdż, Maria Krzemińska Pakuła 2nd Chair and Department

More information

PERCUTANEOUS MITRAL VALVE THERAPIES 13 TH ANNUAL CARDIAC, VASCULAR AND STROKE CARE CONFERENCE PIEDMONT ATHENS REGIONAL

PERCUTANEOUS MITRAL VALVE THERAPIES 13 TH ANNUAL CARDIAC, VASCULAR AND STROKE CARE CONFERENCE PIEDMONT ATHENS REGIONAL PERCUTANEOUS MITRAL VALVE THERAPIES 13 TH ANNUAL CARDIAC, VASCULAR AND STROKE CARE CONFERENCE PIEDMONT ATHENS REGIONAL DISCLOSURES I WILL BE DISCUSSING OFF-LABEL USAGE OF DEVICES RELATED TO TMVR OBJECTIVES

More information

We present the case of an asymptomatic, 75-year-old

We present the case of an asymptomatic, 75-year-old Images in Cardiovascular Medicine Asymptomatic Rupture of the Left Ventricle Lech Paluszkiewicz, MD; Stefan Ożegowski, MD; Mohammad Amin Parsa, MD; Jan Gummert, PhD, MD We present the case of an asymptomatic,

More information

Surgical Mininvasive Approach for Mitral Repair Prof. Mauro Rinaldi

Surgical Mininvasive Approach for Mitral Repair Prof. Mauro Rinaldi Surgical Mininvasive Approach for Mitral Repair Prof. Mauro Rinaldi SC Cardiochirurgia U Universita degli Studi di Torino PORT-ACCESS TECNIQUE Reduce surgical trauma Minimize disruption of the chest wall

More information

좌심실수축기능평가 Cardiac Function

좌심실수축기능평가 Cardiac Function Basic Echo Review Course 좌심실수축기능평가 Cardiac Function Seonghoon Choi Cardiology Hallym university LV systolic function Systolic function 좌심실수축기능 - 심근의수축으로심실에서혈액을대동맥으로박출하는기능 실제임상에서 LV function 의의미 1Diagnosis

More information

: mm 86 mm EF mm

: mm 86 mm EF mm 37 Vol. 35, pp. 37 42, 2007 2 3 : 9 6 22 68 40 2003 4 Ejection fraction: EF44 IV 70 mm 86 mm EF46 6 24 mm 4 mm EF 80 60 mm 70 mm Aortic Regurgitation: AR 2 3 AR Aortic Valve Replacement: AVR AR 38 : 68

More information

8/31/2016. Mitraclip in Matthew Johnson, MD

8/31/2016. Mitraclip in Matthew Johnson, MD Mitraclip in 2016 Matthew Johnson, MD 1 Abnormal Valve Function Valve Stenosis Obstruction to valve flow during that phase of the cardiac cycle when the valve is normally open. Hemodynamic hallmark - pressure

More information

Long term outcomes of posterior leaflet folding valvuloplasty for mitral valve regurgitation

Long term outcomes of posterior leaflet folding valvuloplasty for mitral valve regurgitation Featured Article Long term outcomes of posterior leaflet folding valvuloplasty for mitral valve regurgitation Igor Gosev 1, Maroun Yammine 1, Marzia Leacche 1, Siobhan McGurk 1, Vladimir Ivkovic 1, Michael

More information

MITRAL REGURGITATION ECHO PARAMETERS TOOL

MITRAL REGURGITATION ECHO PARAMETERS TOOL Comprehensive assessment of qualitative and quantitative parameters, along with the use of standardized nomenclature when reporting echocardiographic findings, helps to better define a patient s MR and

More information

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal I have nothing to disclose. Wide Spectrum Stable vs Decompensated NYHA II IV? Ejection

More information

Bogdan A. Popescu. University of Medicine and Pharmacy Bucharest, Romania. EAE Course, Bucharest, April 2010

Bogdan A. Popescu. University of Medicine and Pharmacy Bucharest, Romania. EAE Course, Bucharest, April 2010 Bogdan A. Popescu University of Medicine and Pharmacy Bucharest, Romania EAE Course, Bucharest, April 2010 This is how it started Mitral stenosis at a glance 2D echo narrow diastolic opening of MV leaflets

More information

Surgery for mitral regurgitation Repair versus valve replacement*

Surgery for mitral regurgitation Repair versus valve replacement* European Heart Journal (1986) 7, 638-643 Surgery for mitral regurgitation versus valve replacement* H. P. KRAYENBUEHL Medical Policlinic, Cardiology, University Hospital, CH-8091, Zurich, Switzerland KEY

More information

(Ann Thorac Surg 2008;85:845 53)

(Ann Thorac Surg 2008;85:845 53) I Made Adi Parmana The utility of intraoperative TEE has become increasingly more evident as anesthesiologists, cardiologists, and surgeons continue to appreciate its potential application as an invaluable

More information

THE FOLDING LEAFLET. Rafael García Fuster. Cardiac Surgery Department University General Hospital of Valencia

THE FOLDING LEAFLET. Rafael García Fuster. Cardiac Surgery Department University General Hospital of Valencia THE FOLDING LEAFLET Rafael García Fuster Cardiac Surgery Department University General Hospital of Valencia School of Medicine Catholic University of Valencia San Vicente Mártir SPAIN Carpentier s principles

More information

Σεμινάρια Ομάδων Εργασίας 2017 Ανεπάρκεια μιτροειδούς μυξωματώδους αιτιολογίας

Σεμινάρια Ομάδων Εργασίας 2017 Ανεπάρκεια μιτροειδούς μυξωματώδους αιτιολογίας Σεμινάρια Ομάδων Εργασίας 2017 Ανεπάρκεια μιτροειδούς μυξωματώδους αιτιολογίας Μυτάς Δημήτρης MD, PhD Επιμ Α ΕΣΥ Σισμανόγλειο Γενικό Νοσοκομείο Αττικής Δηλώνω υπεύθυνα ότι η παρούσα ομιλία δεν επιχορηγείται

More information

Congestive Heart Failure or Heart Failure

Congestive Heart Failure or Heart Failure Congestive Heart Failure or Heart Failure Dr Hitesh Patel Ascot Cardiology Group Heart Failure Workshop April, 2014 Question One What is the difference between congestive heart failure and heart failure?

More information

Degenerative mitral regurgitation (MR) is the second

Degenerative mitral regurgitation (MR) is the second Valvular Heart Disease Outcome of Watchful Waiting in Asymptomatic Severe Mitral Regurgitation Raphael Rosenhek, MD; Florian Rader, MD; Ursula Klaar, MD; Harald Gabriel, MD; Marcel Krejc, PhD; Daniel Kalbeck,

More information

Atrial dyssynchrony syndrome: An overlooked cause of heart failure with normal ejection fraction

Atrial dyssynchrony syndrome: An overlooked cause of heart failure with normal ejection fraction Atrial dyssynchrony syndrome: An overlooked cause of heart failure with normal ejection fraction JC Eicher, G Laurent, O Barthez, A Mathé, G Bertaux, JE Wolf Heart Failure Treatment Unit, Rhythmology and

More information

Steven F Bolling Professor of Cardiac Surgery University of Michigan

Steven F Bolling Professor of Cardiac Surgery University of Michigan Optimal Treatment of Functional MR Steven F Bolling Professor of Cardiac Surgery University of Michigan Functional MR Functional MR in Ischemia Badhwar, Bolling, chapter in: Advances in Heart Failure,

More information

Case Report. Percutaneous Mitral Repair with MitraClip as an Adjunct Therapy of Heart Failure. Introduction. Case Report. Keywords

Case Report. Percutaneous Mitral Repair with MitraClip as an Adjunct Therapy of Heart Failure. Introduction. Case Report. Keywords Percutaneous Mitral Repair with MitraClip as an Adjunct Therapy of Heart Failure Petherson Susano Grativvol, 1,2 Katiuska Massucatti Grativvol, 1,2 Alberto de Paula Nogueira Jr., 1,2 João Eduardo Tinoco

More information

Valvular Guidelines: The Past, the Present, the Future

Valvular Guidelines: The Past, the Present, the Future Valvular Guidelines: The Past, the Present, the Future Robert O. Bonow, MD, MS Northwestern University Feinberg School of Medicine Bluhm Cardiovascular Institute Northwestern Memorial Hospital Editor-in-Chief,

More information

Severe left ventricular dysfunction and valvular heart disease: should we operate?

Severe left ventricular dysfunction and valvular heart disease: should we operate? Severe left ventricular dysfunction and valvular heart disease: should we operate? Laurie SOULAT DUFOUR Hôpital Saint Antoine Service de cardiologie Pr A. COHEN JESFC 16 janvier 2016 Disclosure : No conflict

More information

Midterm Outcomes Using the Physio Ring in Mitral Valve Reconstruction: Experience in 492 Patients

Midterm Outcomes Using the Physio Ring in Mitral Valve Reconstruction: Experience in 492 Patients Midterm Outcomes Using the Physio Ring in Mitral Valve Reconstruction: Experience in 492 Patients Kevin D. Accola, MD, Meredith L. Scott, MD, Paul A. Thompson, MD, George J. Palmer III, MD, Mark E. Sand,

More information

Three-Dimensional P3 Tethering Angle at the Heart of Future Surgical Decision Making in Ischemic Mitral Regurgitation

Three-Dimensional P3 Tethering Angle at the Heart of Future Surgical Decision Making in Ischemic Mitral Regurgitation Accepted Manuscript Three-Dimensional P3 Tethering Angle at the Heart of Future Surgical Decision Making in Ischemic Mitral Regurgitation Wobbe Bouma, MD PhD, Robert C. Gorman, MD PII: S0022-5223(18)32805-8

More information

Tricuspid and Pulmonary Valve Disease

Tricuspid and Pulmonary Valve Disease Tricuspid and Pulmonary Valve Disease Lawrence Rudski MD FRCPC FACC FASE Professor of Medicine Director, Division of Cardiology Jewish General Hospital McGill University Right Sided Failure Edema Gut congestion

More information